Year: 1997
Type: article
Study design: Observational Study
Abstract: Acute myeloid leukaemia (AML) with the t(8;21)(q22;q22) is deemed to be a 'good-risk' disease. 396 patients with AML at diagnosis were screened for the presence of t(8;21) and AML1/ETO fusion transcripts by cytogenetic and RT-PCR techniques respectively. 32 cases of t(8;21) were detected, all of which were also PCR positive. A further 19 cases were detected at the molecular level, predominantly but not exclusively in M1 and M2 FAB types. Approximately 12% of all new cases of AML are estimated to have AML1/ETO fusion transcripts and it is suggested that molecular screening should be performed in all cases with the possible exception of the M3 FAB type.
Source: British Journal of Haematology
Authors: S. E. Langabeer, H. Walker, J. R. Rogers, A. K. Burnett, K. Wheatley, D. Swirsky, A. H. Goldstone, D. C. Linch, on behalf of the MRC Adult Leukaemia Working Party
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2017662524
